External beam radiotherapy for patients presenting with hormone sensitive, low volume metastatic prostate cancer at the time of diagnosis

Overview

NHS England has launched a 30 day consultation on the use of external beam radiotherapy for patients presenting with hormone sensitive, low volume metastatic prostate cancer at the time of diagnosis.

The proposal is that this form of radiotherapy is recommended to be available as a treatment option for this indication, as set out within the criteria in the policy proposition.

A final decision will made by NHS England following a recommendation from the Clinical Priorities Advisory Group.

Related documents

• Policy Proposition
• Stakeholder Engagement Report
• Impact Assessment
• Evidence Review
• Evidence Report following stakeholder testing
• CPAG Summary Report
• Clinical Panel Report
• Equality and Health Inequalities Impact Assessment